Nancy Zhou

Discovery of <i>N</i>-(2-Aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide (MGCD0103), an Orally Active Histone Deacetylase Inhibitor

Nancy Zhou, Oscar Moradei, Stéphane Raeppel et al. · Journal of Medicinal Chemistry · 2008 · 108 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors

Michael R. Mannion, Stéphane Raeppel, Stephen Claridge et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 50 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors

Isabelle Paquin, Stéphane Raeppel, Silvana Leit et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 35 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7

N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: A novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors

Stéphane Raeppel, Stephen Claridge, Oscar Saavedra et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 34 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: Novel classes of histone deacetylase inhibitors

Oscar Moradei, Silvana Leit, Nancy Zhou et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 29 citations · Full text

Natural Sciences, Chemistry, Medicinal Chemistry +7